Strix
64.8K

CVE-2026-66875

HIGHCVSS 8.8/10EPSS 0.27%

Last modified

CVE-2026-66875 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates.. EPSS estimates a 0.27% chance of exploitation in the next 30 days.

Description

In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates.

Metrics

CVSS 3.1
8.8/10

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

CVSS 4.0
8.7/10

CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

EPSS Probability
0.27%

18.5th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Source: CNA advisory (CVE.org). NVD analysis pending.

VendorProductVersions
Quanovate Tech Inc. (operating as Mira / Mira Care)Mira Firmware1.7.1.47
Quanovate Tech Inc. (operating as Mira / Mira Care)Mira Android App4.5.15.4

References

Timeline

Published
Last Modified
Status
Awaiting Analysis

Frequently Asked Questions

What is CVE-2026-66875?
In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates.
How severe is CVE-2026-66875?
CVE-2026-66875 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 0.27% probability of exploitation in the next 30 days.
How do I fix CVE-2026-66875?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

View all 2026CVEs →

Are you affected by CVE-2026-66875?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST